Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Agreements For Medicines Dispensed At The Expense Of Statutory Health Insurance Companies 2027-01-05
Germany Open House Drug Discount Agreements Botulinum Toxin Type A, Finished Medicinal Product Name Xeomin(r), Atc M03ax21 2027-01-05
Germany Open House Drug Discount Agreements Goserelin, Atc L02ae03 2027-01-05
Germany Open House Drug Discount Contracts Colecalciferol, Non Rx, Exclusively According To Annex 1 Am-rl G-ba Prescribable Products, Atc A11cc05 2027-01-05
Germany Open House Drug Discount Agreements Colecalciferol, Non Rx, Exclusively According To Appendix 1 Amrl Gba Prescribable Products, Atc A11cc05 - Drug 2027-01-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Sgb V For The Active Ingredient Nebivolol, (obg) Atc C07ab12 For The Period 01.03.2025 - 28.02.2027 2027-01-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Of The Social Security Code (sgb V) For The Active Ingredient Elbasvir + Grazoprevir, (obo) Atc J05ap54 For The Period 01.03.2025 - 28.02.2027 2027-01-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Bempedoic Acid, (obo) Atc C10ax15 For The Period 01.03.2025 28.02.2027 2027-01-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Clobazam, (obg) Atc N05ba09 For The Period 01.03.2025 28.02.2027 2027-01-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Paragraph 8 Sgb V For The Active Ingredient Ustekinumab, (obg) Atc L04ac05 For The Period 01.03.2025 - 28.02.2027 2027-01-05
Whats app